Mendelspod Podcast

Mendelspod was founded in 2011 by Theral Timpson and Ayanna Monteverdi to advance life science research, connecting people and ideas. Influenced by the thinking tools developed by Eli Goldgratt, the founders bring a unique approach to media in the life sciences. With help from our advisors around the industry, Mendelspod goes beyond quick sound bites to create a space for probing conversations and deep insight into the topics and trends which shape the industry's future and therefore our future as a species.

https://mendelspod.com/

Eine durchschnittliche Folge dieses Podcasts dauert 29m. Bisher sind 472 Folge(n) erschienen. Dieser Podcast erscheint alle 5 Tage
subscribe
share





Matt Loose on "Read Until" or Adaptive Sequencing


Back before the world turned upside down, you know, all those years ago, like early this February . . . a paper popped up on bioRxiv called, “Nanopore adaptive sequencing for mixed samples, whole exome capture and targeted panels". It’s an interesting paper...


share







   n/a
 
 

The Current State of Coronavirus Vaccines with Jeff Stein, Cidara Therapeutics


What is the key to getting a coronavirus vaccine? “Manufacturing,” says today’s guest, Jeff Stein of Cidara Therapeutics. Jeff joined us just last fall to talk about his company’s exciting new technology, an immunotherapy, that is a universal flu preventative and therapy. Yes, you read that right. A universal flu preventative.


share







   n/a
 
 

April 2020 Review with Nathan and Laura: Ioannidis Scandal, Antibody Testing, Ethics Questions


Our commentators, Nathan Pearson of Root and Laura Hercher of Sarah Laurence College, join us to look back on month two of the first modern pandemic. We begin with a scandal that rocked the Twitter science community and talk about how science itself may be having a big moment. Will this be a silver lining for this strange year? Then it’s on to antibody testing...


share







   n/a
 
 

The Challenges of Coronavirus Testing with Elaine Lyon, Lab Director, HudsonAlpha


Why have diagnostic tests for the Coronavirus been slow on the scene? What have been the challenges for lab directors? Were they scientific? Were they regulatory? Were they scaling challenges? Are they still scaling challenges? Supply chain problems? Elaine Lyon worked for many years at the molecular genetics lab at ARUP at the University of Utah and is now the Clinical Services Lab Director at Hudson Alpha...


share







 2020-04-14  n/a
 
 

Lab Director Speaks to the Challenges of COVID-19 Testing: Elaine Lyon, HudsonAlpha


Why have diagnostic tests for the Coronavirus been slow on the scene? What have been the challenges for lab directors? Were they scientific? Were they regulatory? Were they scaling challenges? Are they still scaling challenges? Supply chain problems? Elaine Lyon worked for many years at the molecular genetics lab at ARUP at the University of Utah and is now the Clinical Services Lab Director at Hudson Alpha...


share







 2020-04-14  n/a
 
 

The Challenges of Diagnostic Coronavirus Testing with Elaine Lyon, HudsonAlpha


Why have diagnostic tests for the Coronavirus been slow on the scene? What have been the challenges for lab directors? Were they scientific? Were they regulatory? Were they scaling challenges? Are they still scaling challenges? Supply chain problems? Elaine Lyon worked for many years at the molecular genetics lab at ARUP at the University of Utah and is now the Clinical Services Lab Director at Hudson Alpha...


share







 2020-04-14  n/a
 
 
share







 2020-04-07  n/a
 
 

FDA in the Time of Coronavirus: Understanding the New VALID Act with Turna Ray, GenomeWeb


After the virus reached American shores was the FDA quick enough to allow companies and labs to develop their own tests without restrictive oversight? The question sparked a sweeping new bill in congress, the VALID Act that could overhaul FDA oversight of diagnostics altogether—something that has been clamored for for a generation. Turna Ray has been covering the FDA and diagnostics for GenomeWeb since 2006...


share







 2020-04-07  n/a
 
 

March 2020 Review with Nathan & Laura: Corona Gets Personal, Where Are the Tests?, the VALID Act, Some non-Corona Science


Laura comes to us from her flat in New York, Nathan is stuck in San Diego, but they are here and ready to discuss what a month ago was a warning and now is a full blown world crisis. What have they faced personally? What are their thoughts on testing? And what are some of their early big picture reactions as to how this will all go down? We make some time for some Corona-free science as well.


share







 2020-04-02  n/a
 
 

90% Go Undiagnosed, Says Geisinger’s Amy Sturm of FH Patients


More than one in two hundred people have an inherited form of heart disease. But most don’t know it. Often on Mendelspod we talk about cancer genomics, but in the area of cardio too, genetic testing can save lives. Amy Sturm is the Director of Genomic Counseling and Screening Program at Geisinger Health Systems. There she has led the effort to return the results of cardio genetic tests to over 1,000 patients.


share







 2020-03-26  n/a